Below is information about ENOBIA PHARMA HEADQUARTERS from a variety of sources. Please take a look at the materials that our team has selected for you.
https://www.crunchbase.com/organization/enobia-pharma#:~:text=Where%20is%20Enobia%20Pharma%20%27s%20headquarters%3F%20Enobia%20Pharma,investors%20including%20CTI%20Capital%20and%20Desjardins%20Venture%20Capital.
https://www.cbinsights.com/company/enobia-pharma
Enobia Pharma Headquarter Location. 2901, Rachel Street East #23. Montreal, Quebec, H1W 4A4, Canada
https://www.crunchbase.com/organization/enobia-pharma
Where is Enobia Pharma 's headquarters? Enobia Pharma is located in Montreal, Quebec, Canada. Who invested in Enobia Pharma? Enobia Pharma has 8 investors including CTI Capital and Desjardins Venture Capital. How much funding has Enobia Pharma raised to date? Enobia Pharma has raised $158.4M. When was the last funding round for Enobia Pharma?
https://www.linkedin.com/company/enobia-pharma
Headquarters Montreal, Quebec Type Privately Held Locations Primary 2901, Rachel Street East, #23 Montreal, Quebec H1W 4A4, CA ... Enobia Pharma | …
https://pitchbook.com/profiles/company/52644-07
Information on acquisition, funding, cap tables, investors, and executives for Enobia Pharma. Use the PitchBook Platform to explore the full profile. Log in Request a free trial. Request a free trial Log in. Products; Solutions; Data; News & Analysis ... EUROPEAN Headquarters +44 (0) 20 8037.2308; 1st Floor Saffron House; 6-10 Kirby Street ...
https://www.bloomberg.com/profile/company/0114533D:CN
Company profile page for Enobia Pharma Corp including stock price, company news, press releases, executives, board members, and contact information
https://ca.linkedin.com/company/enobia-pharma
Enobia Pharma | 1,328 followers on LinkedIn. Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments. Our lead product in development, ENB-0040 (human recombinant tissue non-specific alkaline phosphatase), is a subcutaneous bone-targeted enzyme replacement therapy for the rare disease hyposphostasia.
https://ir.alexion.com/news-releases/news-release-details/alexion-completes-acquisition-enobia-pharma-corp
CHESHIRE, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company has completed its previously announced acquisition of 100% of the capital stock of Enobia Pharma Corp., a private biopharmaceutical company focused on the development of therapies to treat patients with ultra-rare and life-threatening genetic …
https://www.centerwatch.com/articles/21834
Alexion to acquire Enobia Pharma for $610 million. Alexion Pharmaceuticals and Enobia Pharma have signed a definitive agreement under which Alexion will acquire 100% of the capital stock of Enobia. Enobia is a private biopharmaceutical company based in Montreal, Canada and Cambridge, Massachusetts, which is focused on the development of therapies to …
https://www.bizjournals.com/boston/news/2011/12/29/alexion-to-acquire-enobia.html
In May, Enobia announced its plans to site a U.S. headquarters in Cambridge. The company already had a presence renting office space in Cambridge, but the new U.S. headquarters will sublet the ...
Everyday Stories. Our journey to bring life-changing therapies to people living with rare diseases has been as innovative as the medicines themselves. For three decades, our researchers and scientific leaders have been pioneering new pathways for research and development in rare disease with unyielding perseverance.
Did you find the information you need about ENOBIA PHARMA HEADQUARTERS?
We hope you found all the information about ENOBIA PHARMA HEADQUARTERS you were looking for and more.
